These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 102631)

  • 41. In vitro susceptibility pattern of cephalosporin-resistant Gram-negative bacteria.
    Punpanich W; Tantichattanon W; Wongwatcharapaiboon S; Treeratweeraphong V
    J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S21-7. PubMed ID: 19255989
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro activity profile of ceftobiprole, an anti-MRSA cephalosporin, against recent gram-positive and gram-negative isolates of European origin.
    Pillar CM; Aranza MK; Shah D; Sahm DF
    J Antimicrob Chemother; 2008 Mar; 61(3):595-602. PubMed ID: 18218646
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of concentration on bactericidal activity of cefotaxime.
    Shah PM; Troche G; Stille W
    J Antimicrob Chemother; 1979 Jul; 5(4):419-22. PubMed ID: 114510
    [No Abstract]   [Full Text] [Related]  

  • 44. Bactericidal activity of cefoperazone in comparison with other beta-lactam antibiotics and gentamicin.
    Welch DF; Matsen JM
    Clin Ther; 1980; 3(Spec Issue):127-9. PubMed ID: 6446385
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro activity of cefdinir (FK 482, PD 134393, CI-983): a new orally active cephalosporin.
    Qadri SM; Ueno Y; Saldin H; Cunha BA
    Chemotherapy; 1993; 39(2):112-9. PubMed ID: 8458243
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Antibacterial activity of cephem antibiotics against isolates from clinical specimens at the Yokohama City University Hospital].
    Kaminaga Y; Sato Y; Hanada K; Ito A
    Jpn J Antibiot; 1986 Oct; 39(10):2547-56. PubMed ID: 3543429
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro efficacy of Bay k 4999, a new ureido-penicillin, in combination with aminoglycosides against Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae and Proteus strains.
    Daschner FD; Steffens A; Langmaack H
    Chemotherapy; 1979; 25(5):282-5. PubMed ID: 113178
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In-vitro activity of pefloxacin compared to other antibiotics.
    Yourassowsky E; Van der Linden MP; Crokaert F; Glupczynski Y
    J Antimicrob Chemother; 1986 Apr; 17 Suppl B():19-28. PubMed ID: 3086279
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In-vitro anti-microbial susceptibility of clinical isolates of pathogenic bacteria to ten antibiotics including phosphomycin.
    Eke PI; Rotimi VO
    Afr J Med Med Sci; 1987 Mar; 16(1):1-8. PubMed ID: 3037870
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In-vitro antibacterial activity of cefepime: a multicentre study.
    Duval J; Soussy CJ; Acar JF; Bergogne-Bérézin E; Cluzel R; Thabaut A; Courvalin P; Grès JJ; Rollin C
    J Antimicrob Chemother; 1993 Nov; 32 Suppl B():55-61. PubMed ID: 8150767
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Cefpirome (HR 810). A new broad spectrum cephalosporin].
    Bryskier A; Chantot JF
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):477-81. PubMed ID: 3937123
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
    Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
    J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro antibacterial activity of FK037, a novel parenteral broad-spectrum cephalosporin.
    Mine Y; Watanabe Y; Sakamoto H; Hatano K; Kuno K; Higashi Y; Kamimura T; Matsumoto Y; Tawara S; Matsumoto F
    J Antibiot (Tokyo); 1993 Jan; 46(1):71-87. PubMed ID: 8436562
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative in vitro activity of LY 127935 (6059-S), seven cephalosporins, three aminoglycosides, carbenicillin, and ticarcillin.
    Watanakunakorn C; Glotzbecker C
    J Antibiot (Tokyo); 1979 Oct; 32(10):1019-24. PubMed ID: 528361
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vitro bactericidal activity of cefepime and cefpirome against clinical isolates at Karachi.
    Arsalan A; Naqvi SB; Ali SA; Ahmed S; Shakeel O
    Pak J Pharm Sci; 2015 May; 28(3):841-7. PubMed ID: 26004702
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vitro antibacterial activity and susceptibility of cefsulodin, an antipseudomonal cephalosporin, to beta-lactamases.
    King A; Shannon K; Phillips I
    Antimicrob Agents Chemother; 1980 Feb; 17(2):165-9. PubMed ID: 6770753
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Susceptibility of "enterobacteria" to penicillins, cephalosporins, lincomycins, erythromycin, and rifampin.
    Finland M; Garner C; Wilcox C; Sabath LD
    J Infect Dis; 1976 Aug; 134 Suppl():S75-96. PubMed ID: 823280
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Effect of combination of hetacillin, cephapirin and amikacin (author's transl)].
    Takahashi M; Ichiman Y; Usui Y; Narikawa S; Yoshida K
    Jpn J Antibiot; 1979 Aug; 32(8):830-8. PubMed ID: 114683
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro evaluation of Ro 13-9904.
    Hinkle AM; Bodey GP
    Antimicrob Agents Chemother; 1980 Oct; 18(4):574-8. PubMed ID: 6778383
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of a new cephalosporin antibiotic, cephapirin.
    Wiesner P; MacGregor R; Bear D; Berman S; Holmes K; Turck M
    Antimicrob Agents Chemother; 1972 Apr; 1(4):303-9. PubMed ID: 4208896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.